Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.


BACKGROUND Neutrophil-to-lymphocyte ratio (NLR), if elevated, is associated with worse outcomes in several malignancies. OBJECTIVE Investigation of NLR at baseline and during therapy for metastatic renal cell carcinoma. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of 1199 patients from the International Metastatic Renal Cell Carcinoma… (More)
DOI: 10.1016/j.eururo.2016.02.033


3 Figures and Tables

Slides referencing similar topics